Shares of Pharming Group (NASDAQ:PHAR – Get Rating) gapped up before the market opened on Monday . The stock had previously closed at $10.99, but opened at $11.35. Pharming Group shares last traded at $11.49, with a volume of 30 shares traded.

Analyst Ratings Changes

Separately, TheStreet raised shares of Pharming Group from a "d+" rating to a "c" rating in a research note on Monday, August 15th.

Pharming Group Stock Up 2.0 %

The business's 50 day moving average price is $10.65 and its 200-day moving average price is $9.37. The firm has a market capitalization of $763.12 million, a PE ratio of 27.95 and a beta of -0.30. The company has a debt-to-equity ratio of 0.60, a quick ratio of 4.68 and a current ratio of 5.40.

About Pharming Group

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema.

Recommended Stories

• Get a free copy of the StockNews.com research report on Pharming Group (PHAR)
• Power Integrations Stock Can Power Your Portfolio
• Don't Chase Walmart Higher, Wait For Extra Low Prices
• Home Depot Results (and Institutions) Are A Catalyst For Lowe's?
• Agilent Remains In Buy Range Ahead Of Next Week's Q4 Report
• Three Penny Stocks Making Big Moves In November

Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.